Palmitic acid (Hexadecanoic Acid): Technical Use and Protoco
2026-07-06
Palmitic acid (hexadecanoic acid, SKU N2456) addresses the need for a high-purity, well-characterized saturated long-chain fatty acid in research focused on lipid metabolism, protein palmitoylation, and metabolic disorder pathways. It is unsuitable for aqueous-based protocols or workflows requiring prolonged solution stability, so precise handling and preparation are critical to ensure reproducible results.
Coronavirus Macrodomains Counteract PARP-Mediated Antiviral
2026-07-05
Grunewald et al. (2019) uncovered that the coronavirus macrodomain is essential for evading poly (ADP-ribose) polymerase (PARP)-mediated inhibition of viral replication and for limiting interferon production, highlighting the pivotal roles of PARP12 and PARP14 in innate immunity. This work clarifies the molecular interplay between viral macrodomains and host ADP-ribosylation, suggesting new directions for antiviral research and pharmacological targeting.
MK-2206 dihydrochloride: Unraveling Akt Pathway Suppression
2026-07-04
Explore how MK-2206 dihydrochloride, a selective Akt inhibitor, advances research into PI3K/Akt/mTOR signaling, persistent infection, and cancer cell apoptosis. This article uniquely bridges molecular immunology and oncology, revealing assay decisions that stem from the latest mechanistic insights.
Caffeine (1,3,7-trimethylpurine-2,6-dione) in Cancer and Met
2026-07-03
Caffeine’s dual role as an adenosine receptor antagonist and metabolic regulator makes it an indispensable reagent in cancer and obesity research. This article delivers actionable protocols, advanced troubleshooting, and novel insights on leveraging APExBIO’s Caffeine N2379 for robust, reproducible results across in vitro and in vivo systems.
Surface Chemistry of Magnetite–CNCs: Cytocompatibility & Hyp
2026-07-03
This study systematically reveals how surface chemistry of cellulose nanocrystals (CNCs) governs the assembly, magnetic properties, and cytocompatibility of magnetite-based nanocomposites for hyperthermia applications. By elucidating molecular interactions and quantifying heating efficiency, it provides a framework for rational design of safe, biocompatible nanomaterials in biomedical research.
Universal nPEC Method for Dual-Loaded Liposome Encapsulation
2026-07-02
This study introduces a validated nanoparticle exclusion chromatography (nPEC) method for accurately determining the encapsulation efficiency of both hydrophilic and lipophilic drugs in dual-loaded liposomes. Its universal applicability addresses a longstanding analytical challenge, supporting advanced drug delivery and combinatorial therapeutic research.
Gene Expression Predictors of Olaparib Response in Mesotheli
2026-07-02
Borchert et al. (2019) identified homologous recombination repair (HRR) defects—termed 'BRCAness'—in malignant pleural mesothelioma (MPM) that predict enhanced susceptibility to PARP inhibitor (olaparib) therapy, especially in BAP1-mutated lines. Their gene expression profiling establishes new prognostic markers and suggests that targeted therapeutic combinations could improve clinical outcomes for specific MPM subgroups.
Bazedoxifene: Beyond Osteoporosis—Targeting IL-6/GP130 Signa
2026-07-01
Explore Bazedoxifene, a selective estrogen receptor modulator, as a dual-purpose tool in postmenopausal osteoporosis and IL-6/GP130 pathway research. Uncover its unique mechanistic roles, protocol strategies, and the latest translational insights linking estrogen signaling to emerging oncology applications.
Advancing Drug Response Evaluation: Insights from In Vitro O
2026-07-01
Schwartz's dissertation introduces a rigorous framework for distinguishing between drug-induced proliferation arrest and cell death in cancer in vitro models. By systematically comparing relative and fractional viability metrics, the study clarifies key aspects of anti-cancer drug responses and offers refined protocols for interpreting in vitro results—supporting improved translational relevance in oncology drug discovery.
Ciclesonide: Mechanism, Evidence, and Protocols for Asthma R
2026-06-30
Ciclesonide is a prodrug that rapidly converts to the potent glucocorticoid desisobutyryl-ciclesonide, offering high efficacy in asthma and allergic rhinitis models. Its targeted activation in lung tissue enables precise glucocorticoid receptor modulation. APExBIO provides validated Ciclesonide (SKU B3477) supporting reproducible respiratory research.
HLY78: Strategic Wnt/β-Catenin Modulation in Translational R
2026-06-30
This thought-leadership article demystifies the mechanistic role and translational potential of HLY78, a targeted Wnt/β-catenin pathway modulator, with a focus on actionable strategies for researchers in developmental biology, fibrosis, and stem cell modeling. By integrating recent insights from oral fibrosis and stem cell marker induction studies, it provides a roadmap for leveraging HLY78 in advanced experimental systems, while critically evaluating its unique position within the research landscape and outlining future directions for cross-domain innovation.
Ceftolozane Sulfate: Applied Protocols and PK/PD Insights
2026-06-29
Ceftolozane sulfate stands out for its potent, time-dependent bactericidal activity against Pseudomonas aeruginosa, especially resistant strains. Here, we translate the latest PK/PD modeling advances and in vivo workflow optimizations into actionable guidance for researchers aiming to accelerate translational antibacterial studies.
Prostaglandin E2 in Inflammation and Mucosal Protection Rese
2026-06-29
Prostaglandin E2 (PGE2) is a versatile lipid autacoid powering precise experimental models in inflammation, immune regulation, and gastrointestinal protection. This article demystifies protocol nuances and advanced troubleshooting, translating recent network pharmacology insights into actionable workflows for biomedical labs.
Dual AMPA/NMDA Blockade Mitigates Soman-Induced Neurodegener
2026-06-28
The reference study demonstrates that dual-targeting glutamate receptor antagonists, especially IEM-1925, offer superior protection against soman-induced status epilepticus and neurodegeneration in a rat model. These findings highlight the translational potential of AMPA receptor blockade as a neuroprotection strategy in acute organophosphorus neurotoxicity.
ddhCTP (3ʹ-deoxy-3′,4ʹ-didehydro-CTP): Molecular Antiviral T
2026-06-27
Uncover the advanced molecular action of ddhCTP (3ʹ-deoxy-3′,4ʹ-didehydro-CTP) as a targeted RNA virus replication inhibitor. This article reveals new insights into the compound’s mechanism, unique assay considerations, and its strategic role in next-generation antiviral research.
507 records 16/34 page Previous Next First page 上5页 1617181920 下5页 Last page